Susan G. Komen for the Cure(R) Partners with Healthcare IT Leader Emdeon(R) for Innovative Breast Health Awareness Campaigns
NASHVILLE, Tenn., Oct. 1 /PRNewswire-FirstCall/ — Emdeon (NYSE: EM) today announced a partnership with Susan G. Komen for the Cure, the world’s largest breast cancer advocacy organization. Through this partnership, Emdeon’s Web-based software solution, Emdeon Office(TM), will feature Susan G. Komen literature about breast cancer.
The printable materials include topics such as “Breast Cancer Risk Factors”, “When You Discover A Lump”, and “Sexuality and Intimacy” in both English and Spanish formats. There is no limit on the number of times the providers may print the disease prevention and wellness materials.
“Through the Emdeon Office web portal, healthcare providers and their staff can access six different versions of print-on-demand breast health information while interacting with the patient during the normal work flow,” said Geoff Pace, senior vice president of product development for Emdeon, whose department created the web solution for Susan G. Komen for the Cure.
Emdeon Office is an Internet-based solution that enables healthcare providers to conduct everyday administrative transactions, including patient eligibility/benefits verification, claim submission, referrals, authorizations and pre-certifications for care. It is currently in use in professional offices representing nearly 100,000 healthcare professionals across the country.
“This partnership with Emdeon will help deliver potentially life-saving information to providers at the point of care,” said Elizabeth Thompson, vice president of health science at Susan G. Komen for the Cure. “It will enable our breast health messages to reach patients when they need them most, helping to bring us one step closer to a world without breast cancer.”
In addition to exposing thousands of healthcare providers to readily accessible, print-quality patient education downloads, Emdeon is engaging in another campaign to turn America’s mailboxes pink this October. During the month, Emdeon’s print and mail facilities will print outgoing consumer healthcare statement envelopes with a hot pink awareness message that reads, “Are you Inspired to Save a Life? Find out how at www.komen.org/inspire.” The envelopes are expected to reach more than twelve million consumers in the month of October, which is National Breast Cancer Awareness month and the focus of numerous Susan G. Komen for the Cure awareness campaigns.
“It is an honor to partner with Susan G. Komen for the Cure to bring together their important breast health message and our vast footprint in the healthcare markets,” said Miriam Paramore, senior vice president of corporate strategy at Emdeon. “We are committed to making healthcare efficient, and will continue to layer innovative solutions like these on top of our practical products that are already in the market,” Paramore said.
Emdeon (NYSE: EM) is a leading provider of revenue and payment cycle management solutions, connecting payers, providers and patients in the U.S. healthcare system. Emdeon’s product and service offerings integrate and automate key business and administrative functions of its payer and provider customers throughout the patient encounter. Through the use of Emdeon’s comprehensive suite of products and services, which are designed to easily integrate with existing technology infrastructures, customers are able to improve efficiency, reduce costs, increase cash flow and more efficiently manage the complex revenue and payment cycle process. For more information, visit www.emdeon.com.
About Susan G. Komen for the CureÃ‚®
Nancy G. Brinker promised her dying sister, Susan G. Komen, she would do everything in her power to end breast cancer forever. In 1982, that promise became Susan G. Komen for the Cure and launched the global breast cancer movement. Today, Komen for the Cure is the world’s largest grassroots network of breast cancer survivors and activists fighting to save lives, empower people, ensure quality care for all and energize science to find the cures. Thanks to events like the Komen Race for the CureÃ‚®, more than $1.3 billion has been invested to fulfill the promise, becoming the largest source of nonprofit funds dedicated to the fight against breast cancer in the world. For more information about Susan G. Komen for the Cure, breast health or breast cancer, visit www.komen.org or call 1-877 GO KOMEN.
This press release contains forward-looking statements. You should not place undue reliance on those statements because they are subject to numerous uncertainties and factors relating to Emdeon’s operations and business environment, all of which are difficult to predict and many of which are beyond Emdeon’s control. Forward-looking statements include information concerning Emdeon’s possible or assumed future results of operations, including descriptions of Emdeon’s business strategy. These statements often include words such as “may,” “will,” “should,” “believe,” “expect,” “anticipate,” “intend,” “plan,” “estimate” or similar expressions. These statements are based on assumptions that Emdeon has made in light of its experience in the industry as well as its perceptions of historical trends, current conditions, expected future developments and other factors it believes are appropriate under the circumstances. Although Emdeon believes that these forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect Emdeon’s actual financial results or results of operations and could cause actual results to differ materially from those in the forward-looking statements. These factors are discussed in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections and elsewhere in Emdeon’s registration statement with SEC.
You should keep in mind that any forward-looking statement made by Emdeon herein/ or elsewhere, speaks only as of the date on which made. New risks and uncertainties come up from time to time, and other public filings, it is impossible for Emdeon to predict these events or how they may affect it. Emdeon has no obligation to update any forward-looking statements after the date hereof, except as required by federal securities laws.